Apontis Pharma AG Stock price Deutsche Boerse AG

Equities

APPH

DE000A3CMGM5

Pharmaceuticals

Real-time Estimate Tradegate 08:17:49 2024-03-28 am EDT 5-day change 1st Jan Change
6.41 EUR +8.28% Intraday chart for Apontis Pharma AG +2.58% +35.90%
Sales 2023 * 36.23M 39.16M Sales 2024 * 40.53M 43.8M Capitalization 51.65M 55.81M
Net income 2023 * -14M -15.13M Net income 2024 * -2M -2.16M EV / Sales 2023 * 1.04 x
Net cash position 2023 * 13.93M 15.06M Net cash position 2024 * 4.93M 5.33M EV / Sales 2024 * 1.15 x
P/E ratio 2023 *
-3.56 x
P/E ratio 2024 *
-24.5 x
Employees 168
Yield 2023 *
-
Yield 2024 *
-
Free-Float 98%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Apontis Pharma AG

1 day+8.28%
1 week+2.58%
Current month+4.61%
1 month+8.53%
3 months+39.47%
6 months+52.52%
Current year+35.90%
More quotes
1 week
5.90
Extreme 5.9
6.36
1 month
5.76
Extreme 5.76
6.54
Current year
4.00
Extreme 4
6.80
1 year
2.82
Extreme 2.82
12.05
3 years
2.82
Extreme 2.82
27.30
5 years
2.82
Extreme 2.82
27.30
10 years
2.82
Extreme 2.82
27.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 -
Director of Finance/CFO - 21-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 53 20-12-31
Director/Board Member 59 20-12-31
Chairman 50 20-12-31
More insiders
Date Price Change Volume
24-03-28 6.36 +7.43% 0
24-03-27 5.92 +0.34% 0
24-03-26 5.9 -3.59% 600
24-03-25 6.12 -2.55% 0
24-03-22 6.28 +1.29% 0

Delayed Quote Deutsche Boerse AG, March 28, 2024 at 04:37 am EDT

More quotes
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.2 EUR
Average target price
14.67 EUR
Spread / Average Target
+136.56%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Apontis Pharma AG
  4. Stock Apontis Pharma AG - Deutsche Boerse AG